New G protein inhibitor identified, with potential for cancer therapies
RI-MUHC team publishes study in Nature Communications describing a novel molecule that inhibits growth of cancer cells
RI-MUHC team identifies potential diagnostic biomarker for pancreatic cancer
Study demonstrates that regenerative protein 3A/3B promotes a newly recognized precursor of pancreatic...
New study paves the way to novel treatment for Triple Negative Breast Cancer
A team of researchers at the RI-MUHC found two cellular pathways involved in TNBC tumour development...
RI-MUHC study explores how to overcome the resistance of bladder tumours to radiation therapy
Work published in Nature Communications demonstrates a...
RI-MUHC researcher receives inaugural Canadian Cancer Society award
Congratulations to Dr. Julia Valdemarin Burnier!
Morag Park named to the Order of Quebec
The Government of Quebec honours her outstanding contributions to cancer research
The Montreal Children’s Hospital launches the bilingual Opal patient portal app
In a Quebec first, a child’s medical info is just a click away
FALL 2020 CIHR COMPETITION RESULTS
RI-MUHC teams received $6.9 million in project funding and $2 million more for COVID-19 research
RI-MUHC-led team receives $3.4M for new Centre for Applied Nanomedicine
The study of exosomes will foster research on the frontier of personalized medicine
Dr. George Zogopoulos wins Surgical Excellence Award
The McGill career award permits expansion of his pancreatic cancer genetics research program